CoreCap Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-90
Closed -$439 2824
2025
Q1
$439 Buy
+90
New +$541 ﹤0.01% 2731

Other funds holding BLUE

CoreCap Advisors's BLUE Position: Q2 2025 in Review

CoreCap Advisors sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 90 shares — an estimated $439 sold.

CoreCap Advisors first reported a position in BLUE in Q1 2025 and held it in 1 quarter. The position peaked at $439 in Q1 2025. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • CoreCap Advisors reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • CoreCap Advisors sold 90 bluebird bio shares in Q2 2025, an estimated $439.
  • CoreCap Advisors first reported a position in bluebird bio in Q1 2025 and held it in 1 quarter.
  • CoreCap Advisors's bluebird bio position peaked at $439 in Q1 2025.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.